2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
| Autor: | Lorraine O'Driscoll, Niamh McNamee, Sadhbh O’Neill, Vanesa G. Martinez, Richard K. Porter |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
lcsh:Medicine Triple Negative Breast Neoplasms Citrate (si)-Synthase Oxidative phosphorylation Deoxyglucose Biology Article Flow cytometry 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Cell Movement Cancer stem cell Cell Line Tumor medicine Humans Anoikis lcsh:Science Triple-negative breast cancer Multidisciplinary medicine.diagnostic_test Voltage-Dependent Anion Channel 1 lcsh:R Pyruvate Dehydrogenase Acetyl-Transferring Kinase Phenotype Mitochondria 030104 developmental biology chemistry Cell culture Neoplastic Stem Cells Cancer research lcsh:Q Female 2-Deoxy-D-glucose Glycolysis 030217 neurology & neurosurgery |
| Zdroj: | Scientific Reports Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019) |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-019-39789-9 |
| Popis: | Due to limited availability of pharmacological therapies, triple-negative breast cancer (TNBC) is the subtype with worst outcome. We hypothesised that 2-Deoxy-D-Glucose (2-DG), a glucose analogue, may hold potential as a therapy for particularly aggressive TNBC. We investigated 2-DG’s effects on TNBC cell line variants, Hs578T parental cells and their isogenic more aggressive Hs578Ts(i)8 variant, using migration, invasion and anoikis assays. We assessed their bioenergetics by Seahorse. We evaluated metabolic alterations using a Seahorse XF Analyzer, citrate synthase assay, immunoblotting and flow cytometry. We assessed the cancer stem cell (CSC) phenotype of the variants and 2-DG’s effects on CSCs. 2-DG significantly inhibited migration and invasion of Hs578Ts(i)8 versus Hs578T and significantly decreased their ability to resist anoikis. Investigating 2-DG’s preferential inhibitory effect on the more aggressive cells, we found Hs578Ts(i)8 also had significantly decreased oxidative phosphorylation and increased glycolysis compared to Hs578T. This is likely due to mitochondrial dysfunction in Hs578Ts(i)8, shown by their significantly decreased mitochondrial membrane potential. Furthermore, Hs578Ts(i)8 had a significantly increased proportion of cells with CSC phenotype, which was significantly decreased by 2-DG. 2-DG may have benefit as a therapy for TNBC with a particularly aggressive phenotype, by targeting increased glycolysis. Studies of more cell lines and patients’ specimens are warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|